COM503

· Compugen Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COM503, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies [Phase 1]